Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1988 Apr 15;251(2):581–588. doi: 10.1042/bj2510581

Conformational characteristics of receptor-selective opioid peptides. 1H n.m.r. and c.d. spectroscopic studies of delta-kephalin and [Val4]morphiceptin.

M Doi 1, M Tanaka 1, K Ikuma 1, M Nabae 1, K Kitamura 1, M Inoue 1, T Ishida 1
PMCID: PMC1149041  PMID: 2840898

Abstract

An investigation on the conformations of highly receptor-selective opioid peptides was carried out to gain further understanding of the structure-activity relationship of endogenous enkephalins. The preferred conformations of a highly mu-selective [Val4]morphiceptin and a highly delta-selective delta-kephalin have been probed by 1H n.m.r. solvent-, concentration- and temperature-dependences of amide protons to take the folded conformations stabilized by an intramolecular hydrogen bond and the anti-parallely extended dimeric structures respectively. Their possible stereo-conformations were proposed, based on the analyses of the vicinal coupling constants (JHNC alpha H). The conformational difference between the mu- and delta-selective opioid peptides was further ascertained by the c.d. measurements. The c.d. spectra of the mu-selective peptides show negative bands in the range of 210-230 nm, while those of the delta-selective ones show the opposite positive bands. A correlation between c.d. spectra and receptor-selectivity was possible.

Full text

PDF
581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Camerman A., Mastropaolo D., Karle I., Karle J., Camerman N. Crystal structure of leucine-enkephalin. Nature. 1983 Dec 1;306(5942):447–450. doi: 10.1038/306447a0. [DOI] [PubMed] [Google Scholar]
  2. Casy A. F. Solute conformation of enkephalin-like pentapeptides in deuterated dimethylsulphoxide. J Pharm Pharmacol. 1985 Jun;37(6):421–422. doi: 10.1111/j.2042-7158.1985.tb03027.x. [DOI] [PubMed] [Google Scholar]
  3. Chang K. J., Lillian A., Hazum E., Cuatrecasas P., Chang J. K. Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors. Science. 1981 Apr 3;212(4490):75–77. doi: 10.1126/science.6259732. [DOI] [PubMed] [Google Scholar]
  4. Corbett A. D., Gillan M. G., Kosterlitz H. W., McKnight A. T., Paterson S. J., Robson L. E. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor. Br J Pharmacol. 1984 Sep;83(1):271–279. doi: 10.1111/j.1476-5381.1984.tb10143.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Doi M., Tanaka M., Ishida T., Inoue M., Fujiwara T., Tomita K., Kimura T., Sakakibara S., Sheldrick G. M. Crystal structures of [Met5] and [(4-bromo)Phe4,Met5]enkephalins: formation of a dimeric antiparallel beta-structure. J Biochem. 1987 Feb;101(2):485–490. doi: 10.1093/oxfordjournals.jbchem.a121934. [DOI] [PubMed] [Google Scholar]
  6. Fournie-Zaluski M. C., Gacel G., Maigret B., Premilat S., Roques B. P. Structural requirements for specific recognition of mu or delta opiate receptors. Mol Pharmacol. 1981 Nov;20(3):484–491. [PubMed] [Google Scholar]
  7. Gacel G., Fournié-Zaluski M. C., Fellion E., Roques B. P. Evidence of the preferential involvement of mu receptors in analgesia using enkephalins highly selective for peripheral mu or delta receptors. J Med Chem. 1981 Oct;24(10):1119–1124. doi: 10.1021/jm00142a002. [DOI] [PubMed] [Google Scholar]
  8. Grathwohl C., Wüthrich K. Nmr studies of the molecular conformations in the linear oligopeptides H-(L-Ala)n-L-Pro-OH. Biopolymers. 1976 Oct;15(10):2043–2057. doi: 10.1002/bip.1976.360151013. [DOI] [PubMed] [Google Scholar]
  9. Griffin J. F., Langs D. A., Smith G. D., Blundell T. L., Tickle I. J., Bedarkar S. The crystal structures of [Met5]enkephalin and a third form of [Leu5]enkephalin: observations of a novel pleated beta-sheet. Proc Natl Acad Sci U S A. 1986 May;83(10):3272–3276. doi: 10.1073/pnas.83.10.3272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Handa B. K., Land A. C., Lord J. A., Morgan B. A., Rance M. J., Smith C. F. Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur J Pharmacol. 1981 Apr 9;70(4):531–540. doi: 10.1016/0014-2999(81)90364-2. [DOI] [PubMed] [Google Scholar]
  11. Higashijima T., Kobayashi J., Nagai U., Miyazawa T. Nuclear-magnetic-resonance study on Met-enkephalin and Met-enkephalinamide. Molecular association and conformation. Eur J Biochem. 1979 Jun;97(1):43–57. doi: 10.1111/j.1432-1033.1979.tb13084.x. [DOI] [PubMed] [Google Scholar]
  12. Hughes J., Smith T. W., Kosterlitz H. W., Fothergill L. A., Morgan B. A., Morris H. R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975 Dec 18;258(5536):577–580. doi: 10.1038/258577a0. [DOI] [PubMed] [Google Scholar]
  13. Ishida T., Kenmotsu M., Mino Y., Inoue M., Fujiwara T., Tomita K., Kimura T., Sakakibara S. X-ray diffraction studies of enkephalins. Crystal structure of [(4'-bromo) Phe4,Leu5]enkephalin. Biochem J. 1984 Mar 15;218(3):677–689. doi: 10.1042/bj2180677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Khaled M. A., Long M. M., Thompson W. D., Bradley R. J., Brown G. B., Urry D. W. Conformational states of enkephalins in solution. Biochem Biophys Res Commun. 1976 May 23;76(2):224–231. doi: 10.1016/0006-291x(77)90715-x. [DOI] [PubMed] [Google Scholar]
  15. Kosterlitz H. W., Lord J. A., Paterson S. J., Waterfield A. A. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors. Br J Pharmacol. 1980 Feb;68(2):333–342. doi: 10.1111/j.1476-5381.1980.tb10422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mastropaolo D., Camerman A., Camerman N. Crystal structure of methionine-enkephalin. Biochem Biophys Res Commun. 1986 Jan 29;134(2):698–703. doi: 10.1016/s0006-291x(86)80476-4. [DOI] [PubMed] [Google Scholar]
  17. Morley J. S. Structure-activity relationships of enkephalin-like peptides. Annu Rev Pharmacol Toxicol. 1980;20:81–110. doi: 10.1146/annurev.pa.20.040180.000501. [DOI] [PubMed] [Google Scholar]
  18. Mosberg H. I., Hurst R., Hruby V. J., Gee K., Yamamura H. I., Galligan J. J., Burks T. F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5871–5874. doi: 10.1073/pnas.80.19.5871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ohnishi M., Urry D. W. Temperature dependence of amide proton chemical shifts: the secondary structures of gramicidin S and valinomycin. Biochem Biophys Res Commun. 1969 Jul 23;36(2):194–202. doi: 10.1016/0006-291x(69)90314-3. [DOI] [PubMed] [Google Scholar]
  20. Rapaka R. S. Research topics in the medicinal chemistry and molecular pharmacology of opioid peptides--present and future. Life Sci. 1986 Nov 17;39(20):1825–1843. doi: 10.1016/0024-3205(86)90293-6. [DOI] [PubMed] [Google Scholar]
  21. Renugopalakrishnan V., Rapaka R. S., Collette T. W., Carreira L. A., Bhatnagar R. S. Conformational states of Leu5- and Met5-enkephalins in solution. Biochem Biophys Res Commun. 1985 Feb 15;126(3):1029–1035. doi: 10.1016/0006-291x(85)90288-8. [DOI] [PubMed] [Google Scholar]
  22. Roques B. P., Garbay-Jaureguiberry C., Bajusz S., Maigret B. Studies of the conformational behaviour and preferential interactions with opiate receptors of the cis and trans forms of [Dmet2,pro5]enkephalin and [Dmet2,pro5]enkephalinamide by 1H and 13C NMR, theoretical calculations and 13C relaxation measurements. Eur J Biochem. 1980 Dec;113(1):105–119. doi: 10.1111/j.1432-1033.1980.tb06145.x. [DOI] [PubMed] [Google Scholar]
  23. Rose G. D., Gierasch L. M., Smith J. A. Turns in peptides and proteins. Adv Protein Chem. 1985;37:1–109. doi: 10.1016/s0065-3233(08)60063-7. [DOI] [PubMed] [Google Scholar]
  24. Sudha T. S., Balaram P. Conformational flexibility in enkephalins: solvent dependent transitions in peptides with Gly-Gly segments detected by circular dichroism. FEBS Lett. 1981 Nov 2;134(1):32–36. doi: 10.1016/0014-5793(81)80544-3. [DOI] [PubMed] [Google Scholar]
  25. Sudha T. S., Balaram P. Stabilization of beta-turn conformations in enkephalins. alpha-Aminoisobutyric acid analogs. Int J Pept Protein Res. 1983 Apr;21(4):381–388. doi: 10.1111/j.1399-3011.1983.tb03119.x. [DOI] [PubMed] [Google Scholar]
  26. Urry D. W., Long M. M. Conformations of the repeat peptides of elastin in solution: an application of proton and carbon-13 magnetic resonance to the determination of polypeptide secondary structure. CRC Crit Rev Biochem. 1976 Jun;4(1):1–45. doi: 10.3109/10409237609102557. [DOI] [PubMed] [Google Scholar]
  27. Zajac J. M., Gacel G., Petit F., Dodey P., Rossignol P., Roques B. P. Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. Biochem Biophys Res Commun. 1983 Mar 16;111(2):390–397. doi: 10.1016/0006-291x(83)90318-2. [DOI] [PubMed] [Google Scholar]
  28. Zetta L., Cabassi F. 270-MHz 1H nuclear-magnetic-resonance study of met-enkephalin in solvent mixtures. Conformational transition from dimethylsulphoxide to water. Eur J Biochem. 1982 Feb;122(1):215–222. doi: 10.1111/j.1432-1033.1982.tb05869.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES